Loading...
Loading...
- Exela Technologies XELA reported a preliminary third-quarter FY21 revenue decline of 8.5% year-on-year to $279.2 million, missing the consensus of $319.5 million.
- Segments: Revenue for the Information and Transaction Processing Solutions segment declined 11.1% Y/Y to $208.3 million due to lower volumes from COVID-19 and transition revenue roll-off.
- Healthcare Solutions' revenue was flat at $54 million. Legal and Loss Prevention Services revenue increased 1.3% Y/Y to $16.9 million.
- Margins: The gross margin expanded by 90 bps to 24.2%. The adjusted EBITDA margin contracted 292 bps to 13%.
- EPS loss of $(0.09) beat the consensus loss of $(0.12).
- Exela held $170.99 million in cash and equivalents. It used $73.6 million in operating cash flow during the nine months ended September 30.
- Outlook: Exela cut FY21 revenue to $1.16 billion - $1.18 billion from $1.25 billion - $1.39 billion, below the consensus of $1.25 billion.
- Outlook for Gross profit margin of 23% - 25% and Adjusted EBITDA margin of 16% - 17% unchanged.
- Price Action: XELA shares traded lower by 10.5% at $1.79 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in